
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $132.9M | $187.9M | $253.8M | $333.6M | $405.9M | |
Revenue Growth (YoY) | 29.45% | 41.3% | 35.12% | 31.45% | 21.66% | |
Cost of Revenues | $34.9M | $46.8M | $59.9M | $76.3M | $91.5M | |
Gross Profit | $98M | $141.1M | $194M | $257.4M | $314.4M | |
Gross Profit Margin | 73.74% | 75.09% | 76.42% | 77.14% | 77.46% | |
R&D Expenses | $30.5M | $40M | $61.4M | $79.6M | $102.8M | |
Selling, General & Admin | $99.5M | $129.1M | $184.2M | $247.1M | $272M | |
Other Inc / (Exp) | $223K | -$361K | -$580K | -$768K | -$1.4M | |
Operating Expenses | $130M | $169.2M | $245.6M | $326.7M | $374.8M | |
Operating Income | -$32M | -$28.1M | -$51.7M | -$69.3M | -$60.4M | |
Net Interest Expenses | -- | $41K | -- | -- | -- | |
EBT. Incl. Unusual Items | -$31.5M | -$28.5M | -$49.9M | -$65.8M | -$61.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $127K | $211K | $366K | $649K | $670K | |
Net Income to Company | -$31.7M | -$28.7M | -$50.2M | -$66.4M | -$62M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$31.7M | -$28.7M | -$50.2M | -$66.4M | -$62M | |
Basic EPS (Cont. Ops) | -$0.62 | -$0.53 | -$0.92 | -$1.19 | -$1.09 | |
Diluted EPS (Cont. Ops) | -$0.62 | -$0.53 | -$0.92 | -$1.19 | -$1.09 | |
Weighted Average Basic Share | $51.4M | $53.8M | $54.6M | $55.7M | $56.9M | |
Weighted Average Diluted Share | $51.4M | $53.8M | $54.6M | $55.7M | $56.9M | |
EBITDA | -$25.9M | -$23.5M | -$44.8M | -$54.8M | -$45.9M | |
EBIT | -$31.2M | -$28.2M | -$49.7M | -$63M | -$57.8M | |
Revenue (Reported) | $132.9M | $187.9M | $253.8M | $333.6M | $405.9M | |
Operating Income (Reported) | -$32M | -$28.1M | -$51.7M | -$69.3M | -$60.4M | |
Operating Income (Adjusted) | -$31.2M | -$28.2M | -$49.7M | -$63M | -$57.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $40.8M | $57.4M | $75.2M | $96.8M | $109.3M | |
Revenue Growth (YoY) | 33.68% | 40.7% | 30.97% | 28.68% | 12.92% | |
Cost of Revenues | $10M | $14M | $16.9M | $22.4M | $24.8M | |
Gross Profit | $30.8M | $43.4M | $58.3M | $74.4M | $84.5M | |
Gross Profit Margin | 75.51% | 75.64% | 77.56% | 76.83% | 77.27% | |
R&D Expenses | $8.3M | $13.1M | $17.9M | $23.8M | $23.2M | |
Selling, General & Admin | $28.8M | $40M | $52.4M | $63.9M | $72.4M | |
Other Inc / (Exp) | -$119K | -$108K | -$209K | -$406K | -$168K | |
Operating Expenses | $37M | $53M | $70.3M | $87.6M | $95.7M | |
Operating Income | -$6.2M | -$9.6M | -$11.9M | -$13.3M | -$11.2M | |
Net Interest Expenses | $20K | -- | -- | $11K | -- | |
EBT. Incl. Unusual Items | -$6.4M | -$9.7M | -$10.2M | -$13.7M | -$11M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $9K | $90K | $102K | -$129K | $231K | |
Net Income to Company | -$6.4M | -$9.8M | -$10.3M | -$13.6M | -$11.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$6.4M | -$9.8M | -$10.3M | -$13.6M | -$11.2M | |
Basic EPS (Cont. Ops) | -$0.12 | -$0.18 | -$0.19 | -$0.24 | -$0.19 | |
Diluted EPS (Cont. Ops) | -$0.12 | -$0.18 | -$0.19 | -$0.24 | -$0.19 | |
Weighted Average Basic Share | $53.4M | $54.3M | $55.2M | $56.3M | $57.9M | |
Weighted Average Diluted Share | $53.4M | $54.3M | $55.2M | $56.3M | $57.9M | |
EBITDA | -$5.1M | -$8.5M | -$8.7M | -$9.8M | -$7.6M | |
EBIT | -$6.3M | -$9.6M | -$10.1M | -$12.7M | -$10.5M | |
Revenue (Reported) | $40.8M | $57.4M | $75.2M | $96.8M | $109.3M | |
Operating Income (Reported) | -$6.2M | -$9.6M | -$11.9M | -$13.3M | -$11.2M | |
Operating Income (Adjusted) | -$6.3M | -$9.6M | -$10.1M | -$12.7M | -$10.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $143.2M | $204.5M | $271.6M | $355.2M | $418.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $36.7M | $50.8M | $62.7M | $81.8M | $93.9M | |
Gross Profit | $106.5M | $153.7M | $208.9M | $273.4M | $324.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $31.5M | $44.8M | $66.2M | $85.4M | $102.3M | |
Selling, General & Admin | $102.3M | $140.3M | $196.6M | $258.6M | $280.5M | |
Other Inc / (Exp) | $2K | -$350K | -$681K | -$965K | -$1.2M | |
Operating Expenses | $133.8M | $185.2M | $262.9M | $344M | $382.8M | |
Operating Income | -$27.3M | -$31.5M | -$54M | -$70.6M | -$58.3M | |
Net Interest Expenses | $134K | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$27.4M | -$31.8M | -$50.4M | -$69.3M | -$58.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $133K | $292K | $378K | $418K | $1M | |
Net Income to Company | -$27.5M | -$32.1M | -$50.7M | -$69.8M | -$59.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$27.5M | -$32.1M | -$50.7M | -$69.8M | -$59.6M | |
Basic EPS (Cont. Ops) | -$0.52 | -$0.59 | -$0.93 | -$1.25 | -$1.04 | |
Diluted EPS (Cont. Ops) | -$0.52 | -$0.59 | -$0.93 | -$1.25 | -$1.04 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$22M | -$26.8M | -$45M | -$55.9M | -$43.8M | |
EBIT | -$27.1M | -$31.5M | -$50.2M | -$65.6M | -$55.6M | |
Revenue (Reported) | $143.2M | $204.5M | $271.6M | $355.2M | $418.4M | |
Operating Income (Reported) | -$27.3M | -$31.5M | -$54M | -$70.6M | -$58.3M | |
Operating Income (Adjusted) | -$27.1M | -$31.5M | -$50.2M | -$65.6M | -$55.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $40.8M | $57.4M | $75.2M | $96.8M | $109.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $10M | $14M | $16.9M | $22.4M | $24.8M | |
Gross Profit | $30.8M | $43.4M | $58.3M | $74.4M | $84.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $8.3M | $13.1M | $17.9M | $23.8M | $23.2M | |
Selling, General & Admin | $28.8M | $40M | $52.4M | $63.9M | $72.4M | |
Other Inc / (Exp) | -$119K | -$108K | -$209K | -$406K | -$168K | |
Operating Expenses | $37M | $53M | $70.3M | $87.6M | $95.7M | |
Operating Income | -$6.2M | -$9.6M | -$11.9M | -$13.3M | -$11.2M | |
Net Interest Expenses | $20K | -- | -- | $11K | -- | |
EBT. Incl. Unusual Items | -$6.4M | -$9.7M | -$10.2M | -$13.7M | -$11M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $9K | $90K | $102K | -$129K | $231K | |
Net Income to Company | -$6.4M | -$9.8M | -$10.3M | -$13.6M | -$11.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$6.4M | -$9.8M | -$10.3M | -$13.6M | -$11.2M | |
Basic EPS (Cont. Ops) | -$0.12 | -$0.18 | -$0.19 | -$0.24 | -$0.19 | |
Diluted EPS (Cont. Ops) | -$0.12 | -$0.18 | -$0.19 | -$0.24 | -$0.19 | |
Weighted Average Basic Share | $53.4M | $54.3M | $55.2M | $56.3M | $57.9M | |
Weighted Average Diluted Share | $53.4M | $54.3M | $55.2M | $56.3M | $57.9M | |
EBITDA | -$5.1M | -$8.5M | -$8.7M | -$9.8M | -$7.6M | |
EBIT | -$6.3M | -$9.6M | -$10.1M | -$12.7M | -$10.5M | |
Revenue (Reported) | $40.8M | $57.4M | $75.2M | $96.8M | $109.3M | |
Operating Income (Reported) | -$6.2M | -$9.6M | -$11.9M | -$13.3M | -$11.2M | |
Operating Income (Adjusted) | -$6.3M | -$9.6M | -$10.1M | -$12.7M | -$10.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $114.5M | $107.1M | $79.9M | $49.8M | $86.4M | |
Short Term Investments | $49.4M | $69.8M | $92.9M | $44.6M | $3.7M | |
Accounts Receivable, Net | $17.2M | $25.5M | $35.8M | $63.5M | $84M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $9.7M | $6.2M | $6.4M | $10.3M | $15.8M | |
Total Current Assets | $199.3M | $222.5M | $235.5M | $195.9M | $210.2M | |
Property Plant And Equipment | $25.1M | $22.3M | $21.5M | $20.1M | $22.3M | |
Long-Term Investments | -- | -- | $13M | $3.7M | -- | |
Goodwill | $2.3M | $2.3M | $2.3M | $121.4M | $121.3M | |
Other Intangibles | $4.1M | $3M | $2M | $28.1M | $21.9M | |
Other Long-Term Assets | $138K | $126K | $64K | $1.1M | $967K | |
Total Assets | $239.7M | $264.7M | $293.9M | $396.6M | $428.3M | |
Accounts Payable | $1.5M | $2.9M | $5M | $6.9M | $7M | |
Accrued Expenses | $16.5M | $23.6M | $28.6M | $29.6M | $31.4M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $2.2M | $2.7M | $3.5M | $3.9M | $3.7M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $63.6M | $98.4M | $132.8M | $181M | $220.8M | |
Long-Term Debt | -- | -- | -- | $55M | $25M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $87.6M | $119.5M | $151.6M | $252.4M | $261.7M | |
Common Stock | $5K | $5K | $5K | $5K | $5K | |
Other Common Equity Adj | -- | -- | -$369K | -$77K | $3K | |
Common Equity | $152.1M | $145.2M | $142.3M | $144.2M | $166.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $152.1M | $145.2M | $142.3M | $144.2M | $166.6M | |
Total Liabilities and Equity | $239.7M | $264.7M | $293.9M | $396.6M | $428.3M | |
Cash and Short Terms | $163.9M | $176.9M | $172.8M | $94.4M | $90.2M | |
Total Debt | -- | -- | -- | $55M | $25M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $102.3M | $81.7M | $78.4M | $69.2M | $100.9M | |
Short Term Investments | $65.5M | $97.7M | $99.1M | $25M | $1M | |
Accounts Receivable, Net | $15.9M | $23.1M | $36.7M | $50.4M | $64.8M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $7.6M | $9.1M | $10.6M | $18.3M | $19.1M | |
Total Current Assets | $200.9M | $226.8M | $246.4M | $177.7M | $207.5M | |
Property Plant And Equipment | $24.3M | $21.8M | $20.8M | $19.9M | $21.9M | |
Long-Term Investments | -- | $1.5M | $9.7M | $994K | -- | |
Goodwill | $2.3M | $2.3M | $9M | $121.3M | $121.3M | |
Other Intangibles | $3.8M | $2.8M | $3.4M | $26.5M | $20.6M | |
Other Long-Term Assets | $130K | $71K | $66K | $1M | $962K | |
Total Assets | $241.2M | $270.5M | $309.6M | $389.9M | $424.7M | |
Accounts Payable | $705K | $4.8M | $5.7M | $5.7M | $7.3M | |
Accrued Expenses | $13.6M | $23.3M | $27.9M | $26.3M | $29.4M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $2.5M | $2.8M | $3.6M | $4M | $3.5M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $67.6M | $107.3M | $146.3M | $182.4M | $214.1M | |
Long-Term Debt | -- | -- | -- | $45M | $20M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $90.8M | $127.7M | $164.9M | $242.6M | $249.3M | |
Common Stock | $5K | $5K | $5K | $5K | $5K | |
Other Common Equity Adj | -- | -$160K | -$291K | -$48K | $1K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $150.4M | $142.8M | $144.8M | $147.4M | $175.3M | |
Total Liabilities and Equity | $241.2M | $270.5M | $309.6M | $389.9M | $424.7M | |
Cash and Short Terms | $167.8M | $179.3M | $177.5M | $94.2M | $101.9M | |
Total Debt | -- | -- | -- | $45M | $20M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$31.7M | -$28.7M | -$50.2M | -$66.4M | -$62M | |
Depreciation & Amoritzation | $5.3M | $4.7M | $4.9M | $8.2M | $11.9M | |
Stock-Based Compensation | $11.1M | $21.7M | $47.7M | $67.7M | $84.3M | |
Change in Accounts Receivable | -$8.1M | -$8.9M | -$11.5M | -$27M | -$22.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$11.4M | $14.8M | $10.7M | $6.5M | $26.3M | |
Capital Expenditures | $4M | $926K | $1.8M | $2.1M | $3M | |
Cash Acquisitions | -- | -- | -- | -$145.6M | -$1.4M | |
Cash From Investing | -$53.8M | -$22.1M | -$37.7M | -$86.6M | $40.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $75M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$20M | -$30M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$8.1M | -$137K | -$1.9M | -$3.4M | -$2.3M | |
Cash From Financing | $44.4M | -$100K | -$193K | $54M | -$30.3M | |
Beginning Cash (CF) | $135.3M | $114.5M | $107.1M | $79.9M | $53.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$20.8M | -$7.4M | -$27.2M | -$26.2M | $36.7M | |
Ending Cash (CF) | $114.5M | $107.1M | $79.9M | $53.7M | $90.4M | |
Levered Free Cash Flow | -$15.4M | $13.9M | $8.8M | $4.4M | $23.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$6.4M | -$9.8M | -$10.3M | -$13.6M | -$11.2M | |
Depreciation & Amoritzation | $1.2M | $1.1M | $1.4M | $2.9M | $2.9M | |
Stock-Based Compensation | $3.9M | $8.4M | $13.7M | $18.1M | $19.8M | |
Change in Accounts Receivable | $1.1M | $2.3M | -$1.1M | $13M | $18.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $3.6M | $5.4M | $8.3M | $11.2M | $18.1M | |
Capital Expenditures | $173K | $313K | $383K | $1.1M | $1.4M | |
Cash Acquisitions | -- | -- | -$6.4M | -$1.4M | -- | |
Cash From Investing | -$16.5M | -$29.9M | -$8.7M | $20.1M | $1.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$10M | -$5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $621K | -$962K | -$1.1M | -$1.5M | -- | |
Cash From Financing | $644K | -$956K | -$1.1M | -$11.5M | -$5M | |
Beginning Cash (CF) | $114.5M | $107.1M | $79.9M | $53.7M | $90.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$12.2M | -$25.5M | -$1.5M | $19.7M | $14.5M | |
Ending Cash (CF) | $102.3M | $81.7M | $78.4M | $73.4M | $104.9M | |
Levered Free Cash Flow | $3.4M | $5.1M | $7.9M | $10.1M | $16.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$27.5M | -$32.1M | -$50.7M | -$69.8M | -$59.6M | |
Depreciation & Amoritzation | $5.1M | $4.7M | $5.2M | $9.7M | $11.8M | |
Stock-Based Compensation | $11.5M | $26.2M | $53M | $72.1M | $86M | |
Change in Accounts Receivable | -$4.9M | -$7.7M | -$15M | -$12.8M | -$17.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$3.2M | $16.6M | $13.6M | $9.3M | $33.3M | |
Capital Expenditures | $3.9M | $1.1M | $1.9M | $2.8M | $3.2M | |
Cash Acquisitions | -- | -- | -$6.4M | -$140.6M | -- | |
Cash From Investing | -$70M | -$35.5M | -$16.5M | -$57.9M | $22.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$30M | -$25M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$4.3M | -$1.7M | -$2.1M | -$3.8M | -- | |
Cash From Financing | $38.1M | -$1.7M | -$336K | $43.6M | -$23.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$35.1M | -$20.6M | -$3.3M | -$5M | $31.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$7.1M | $15.5M | $11.7M | $6.6M | $30M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$6.4M | -$9.8M | -$10.3M | -$13.6M | -$11.2M | |
Depreciation & Amoritzation | $1.2M | $1.1M | $1.4M | $2.9M | $2.9M | |
Stock-Based Compensation | $3.9M | $8.4M | $13.7M | $18.1M | $19.8M | |
Change in Accounts Receivable | $1.1M | $2.3M | -$1.1M | $13M | $18.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $3.6M | $5.4M | $8.3M | $11.2M | $18.1M | |
Capital Expenditures | $173K | $313K | $383K | $1.1M | $1.4M | |
Cash Acquisitions | -- | -- | -$6.4M | -$1.4M | -- | |
Cash From Investing | -$16.5M | -$29.9M | -$8.7M | $20.1M | $1.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$10M | -$5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $621K | -$962K | -$1.1M | -$1.5M | -- | |
Cash From Financing | $644K | -$956K | -$1.1M | -$11.5M | -$5M | |
Beginning Cash (CF) | $114.5M | $107.1M | $79.9M | $53.7M | $90.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$12.2M | -$25.5M | -$1.5M | $19.7M | $14.5M | |
Ending Cash (CF) | $102.3M | $81.7M | $78.4M | $73.4M | $104.9M | |
Levered Free Cash Flow | $3.4M | $5.1M | $7.9M | $10.1M | $16.7M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.